BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12193534)

  • 1. Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH.
    Sato M; Vahle J; Schmidt A; Westmore M; Smith S; Rowley E; Ma LY
    Endocrinology; 2002 Sep; 143(9):3230-42. PubMed ID: 12193534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment.
    Sato M; Ma YL; Hock JM; Westmore MS; Vahle J; Villanueva A; Turner CH
    J Pharmacol Exp Ther; 2002 Jul; 302(1):304-13. PubMed ID: 12065731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.
    Sato M; Zeng GQ; Turner CH
    Endocrinology; 1997 Oct; 138(10):4330-7. PubMed ID: 9322947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (hPTH 1-34).
    Hirano T; Burr DB; Cain RL; Hock JM
    Calcif Tissue Int; 2000 Jun; 66(6):456-60. PubMed ID: 10821883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of bone neoplasms and persistence of bone efficacy in cynomolgus macaques after long-term treatment with teriparatide [rhPTH(1-34)].
    Vahle JL; Zuehlke U; Schmidt A; Westmore M; Chen P; Sato M
    J Bone Miner Res; 2008 Dec; 23(12):2033-9. PubMed ID: 18684088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.
    Ma YL; Bryant HU; Zeng Q; Schmidt A; Hoover J; Cole HW; Yao W; Jee WS; Sato M
    Endocrinology; 2003 May; 144(5):2008-15. PubMed ID: 12697709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.
    Hirano T; Burr DB; Turner CH; Sato M; Cain RL; Hock JM
    J Bone Miner Res; 1999 Apr; 14(4):536-45. PubMed ID: 10234574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine.
    Fox J; Miller MA; Newman MK; Turner CH; Recker RR; Smith SY
    J Bone Miner Res; 2007 Feb; 22(2):260-73. PubMed ID: 17087625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dramatic increase in cortical thickness induced by femoral marrow ablation followed by a 3-month treatment with PTH in rats.
    Zhang Q; Carlson J; Ke HZ; Li J; Kim M; Murphy K; Mehta N; Gilligan J; Vignery A
    J Bone Miner Res; 2010 Jun; 25(6):1350-9. PubMed ID: 20200940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys.
    Fox J; Miller MA; Newman MK; Recker RR; Turner CH; Smith SY
    Bone; 2007 Sep; 41(3):321-30. PubMed ID: 17573250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats.
    Dobnig H; Turner RT
    Endocrinology; 1997 Nov; 138(11):4607-12. PubMed ID: 9348185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelationships between bone microarchitecture and strength in ovariectomized monkeys treated with teriparatide.
    Chen P; Jerome CP; Burr DB; Turner CH; Ma YL; Rana A; Sato M
    J Bone Miner Res; 2007 Jun; 22(6):841-8. PubMed ID: 17352652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice.
    Iida-Klein A; Lu SS; Kapadia R; Burkhart M; Moreno A; Dempster DW; Lindsay R
    J Endocrinol; 2005 Sep; 186(3):549-57. PubMed ID: 16135674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
    Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sevelamer restores bone volume and improves bone microarchitecture and strength in aged ovariectomized rats.
    Sampath TK; Simic P; Moreno S; Bukanov N; Draca N; Kufner V; Tikvica A; Blair A; Semenski D; Brncic M; Burke SK; Vukicevic S
    Endocrinology; 2008 Dec; 149(12):6092-102. PubMed ID: 18687772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of treatment of ovariectomized adult rhesus monkeys with parathyroid hormone 1-84 for 16 months on trabecular and cortical bone structure and biomechanical properties of the proximal femur.
    Fox J; Miller MA; Recker RR; Turner CH; Smith SY
    Calcif Tissue Int; 2007 Jul; 81(1):53-63. PubMed ID: 17551766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential effects of chronic human PTH (1-84) treatment of estrogen-deficiency osteopenia in the rat.
    Mitlak BH; Burdette-Miller P; Schoenfeld D; Neer RM
    J Bone Miner Res; 1996 Apr; 11(4):430-9. PubMed ID: 8992873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats.
    Lauritzen DB; Balena R; Shea M; Seedor JG; Markatos A; Le HM; Toolan BC; Myers ER; Rodan GA; Hayes WC
    J Bone Miner Res; 1993 Jul; 8(7):871-9. PubMed ID: 8352069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.